PERSPECTIVE THERAPEUTICS, INC.: 10-Q filed 2024-08-13
What PERSPECTIVE THERAPEUTICS, INC. reported in its quarterly report filed 2024-08-13 (fiscal Q2 2024): 39 published measures, 107 facts as tagged in accession 0000950170-24-096148.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2024-08-13
- Fiscal period
- fiscal Q2 2024
- Accession
- 0000950170-24-096148 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All PERSPECTIVE THERAPEUTICS, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-06-30 | 385,919,000 | USD | |
| At 2023-12-31 | 97,891,000 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-06-30 | 44,922,000 | USD | |
| At 2023-12-31 | 22,712,000 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-06-30 | 340,997,000 | USD | |
| At 2024-03-31 | 229,891,000 | USD | |
| At 2023-12-31 | 75,179,000 | USD | |
| At 2023-06-30 | 108,653,000 | USD | |
| At 2023-03-31 | 118,028,000 | USD | |
| At 2022-12-31 | 54,642,000 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-06-30 | 252,004,000 | USD | |
| At 2023-12-31 | 9,238,000 | USD | |
| At 2023-06-30 | 28,319,000 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-04-01 to 2024-06-30 | -11,704,000 | USD | 91 |
| 2024-01-01 to 2024-06-30 | -23,988,000 | USD | 182 |
| 2024-01-01 to 2024-03-31 | -12,284,000 | USD | 91 |
| 2023-04-01 to 2023-06-30 | -11,106,000 | USD | 91 |
| 2023-01-01 to 2023-06-30 | -11,477,000 | USD | 181 |
| 2023-01-01 to 2023-03-31 | -371,000 | USD | 90 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-01-01 to 2024-06-30 | 4,946,000 | USD | 182 |
| 2023-01-01 to 2023-06-30 | -17,795,000 | USD | 181 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-01-01 to 2024-06-30 | 10,087,000 | USD | 182 |
| 2023-01-01 to 2023-06-30 | 756,000 | USD | 181 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-01-01 to 2024-06-30 | 288,412,000 | USD | 182 |
| 2023-01-01 to 2023-06-30 | 432,000 | USD | 181 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-01-01 to 2024-06-30 | -50,592,000 | USD | 182 |
| 2023-01-01 to 2023-06-30 | 24,689,000 | USD | 181 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-06-30 | -176,428,000 | USD | |
| At 2023-12-31 | -152,440,000 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-04-01 to 2024-06-30 | 66,648,000 | shares | 91 |
| 2024-01-01 to 2024-06-30 | 58,079,000 | shares | 182 |
| 2023-04-01 to 2023-06-30 | 27,999,000 | shares | 91 |
| 2023-01-01 to 2023-06-30 | 25,443,000 | shares | 181 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-04-01 to 2024-06-30 | 66,648,000 | shares | 91 |
| 2024-01-01 to 2024-06-30 | 58,079,000 | shares | 182 |
| 2023-04-01 to 2023-06-30 | 27,999,000 | shares | 91 |
| 2023-01-01 to 2023-06-30 | 25,443,000 | shares | 181 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-04-01 to 2024-06-30 | -0.18 | USD/shares | 91 |
| 2024-01-01 to 2024-06-30 | -0.41 | USD/shares | 182 |
| 2023-04-01 to 2023-06-30 | -0.4 | USD/shares | 91 |
| 2023-01-01 to 2023-06-30 | -0.45 | USD/shares | 181 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-04-01 to 2024-06-30 | -0.18 | USD/shares | 91 |
| 2024-01-01 to 2024-06-30 | -0.41 | USD/shares | 182 |
| 2023-04-01 to 2023-06-30 | -0.4 | USD/shares | 91 |
| 2023-01-01 to 2023-06-30 | -0.45 | USD/shares | 181 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-06-30 | 14,747,000 | USD | |
| At 2023-12-31 | 5,576,000 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-01-01 to 2024-06-30 | 1,375,000 | USD | 182 |
| 2023-01-01 to 2023-06-30 | 2,567,000 | USD | 181 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-04-01 to 2024-06-30 | -14,263,000 | USD | 91 |
| 2024-01-01 to 2024-06-30 | -27,268,000 | USD | 182 |
| 2023-04-01 to 2023-06-30 | -9,754,000 | USD | 91 |
| 2023-01-01 to 2023-06-30 | -19,515,000 | USD | 181 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-06-30 | 294,237,000 | USD | |
| At 2023-12-31 | 16,837,000 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-06-30 | 10,610,000 | USD | |
| At 2023-12-31 | 15,664,000 | USD |
Goodwill carrying amount
Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-06-30 | 24,062,000 | USD | |
| At 2023-12-31 | 24,062,000 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-06-30 | 142,000 | USD | |
| At 2023-12-31 | 1,165,000 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-04-01 to 2024-06-30 | 14,789,000 | USD | 91 |
| 2024-01-01 to 2024-06-30 | 28,119,000 | USD | 182 |
| 2023-04-01 to 2023-06-30 | 10,342,000 | USD | 91 |
| 2023-01-01 to 2023-06-30 | 20,336,000 | USD | 181 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-04-01 to 2024-06-30 | 9,275,000 | USD | 91 |
| 2024-01-01 to 2024-06-30 | 16,727,000 | USD | 182 |
| 2023-04-01 to 2023-06-30 | 5,370,000 | USD | 91 |
| 2023-01-01 to 2023-06-30 | 8,679,000 | USD | 181 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-06-30 | 67,425,167 | shares | |
| At 2023-12-31 | 28,180,985 | shares |
Operating lease right-of-use asset
Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-06-30 | 2,019,000 | USD | |
| At 2023-12-31 | 747,000 | USD |
Operating lease liability
Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-06-30 | 2,170,000 | USD |
Long-term debt
Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-06-30 | 1,705,000 | USD |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-06-30 | 16,332,000 | USD | |
| At 2023-12-31 | 6,245,000 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-06-30 | 1,585,000 | USD | |
| At 2023-12-31 | 669,000 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-06-30 | 672,000 | USD | |
| At 2023-12-31 | 487,000 | USD |
Other noncurrent liabilities
Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-06-30 | 19,000 | USD | |
| At 2023-12-31 | 0 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-06-30 | 1,226,000 | USD | |
| At 2023-12-31 | 1,133,000 | USD |
Net deferred tax liabilities
Deferred tax liabilities net of related assets under this concept. The amount reflects timing differences and is not tax currently due.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-06-30 | 4,592,000 | USD | |
| At 2023-12-31 | 4,592,000 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-04-01 to 2024-06-30 | -11,214,000 | USD | 91 |
| 2024-01-01 to 2024-06-30 | -23,039,000 | USD | 182 |
| 2023-04-01 to 2023-06-30 | -9,486,000 | USD | 91 |
| 2023-01-01 to 2023-06-30 | -18,891,000 | USD | 181 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-04-01 to 2024-06-30 | 5,514,000 | USD | 91 |
| 2024-01-01 to 2024-06-30 | 11,392,000 | USD | 182 |
| 2023-04-01 to 2023-06-30 | 4,987,000 | USD | 91 |
| 2023-01-01 to 2023-06-30 | 11,650,000 | USD | 181 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-01-01 to 2024-06-30 | 916,000 | USD | 182 |
| 2023-01-01 to 2023-06-30 | 425,000 | USD | 181 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-04-01 to 2024-06-30 | 3,049,000 | USD | 91 |
| 2024-01-01 to 2024-06-30 | 4,229,000 | USD | 182 |
| 2023-04-01 to 2023-06-30 | 268,000 | USD | 91 |
| 2023-01-01 to 2023-06-30 | 624,000 | USD | 181 |
Deferred income tax expense or benefit
The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-04-01 to 2024-06-30 | 0 | USD | 91 |
| 2024-01-01 to 2024-06-30 | 0 | USD | 182 |
| 2023-04-01 to 2023-06-30 | 0 | USD | 91 |
| 2023-01-01 to 2023-06-30 | -10,500,000 | USD | 181 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-01-01 to 2024-06-30 | -1,023,000 | USD | 182 |
| 2023-01-01 to 2023-06-30 | -250,000 | USD | 181 |
Inspect the source
- Entity
- PERSPECTIVE THERAPEUTICS, INC. / CIK 0000728387
- Captured
- 2026-09-19T15:00:29.793Z
- SEC response SHA-256
80792777921b49454c9d29f110283a1024ec5ce2a3749610d4c1319da49650fe
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000728387.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))